Ericsson / Agency for Healthcare Research / PBT / Highmark Medicare Services Inc. / /
Country
United States / /
Currency
USD / /
Event
FDA Phase / /
Facility
PBT facility / University of Tsukaba / hospital CEOs / University of Florida / N/A University of Pennsylvania / University of California / Facility Date / Massachusetts General Hospital / U.S. National Cancer Institute / Loma Linda University / Health Facility Planning DATE / Northeast Proton Therapy Center / /
IndustryTerm
advisory / treatment of prostate cancer / energy / medical technology / Treatment of Cancer / compact systems / Therapy for prostate cancer / Treatment of Childhood Medulloblastoma / ” Cancer / Therapy for Hodgkin Lymphoma / service delivery site / therapy of cancer / medical technologies / proposed operator / lower cost equipment / Therapies for Cancer / treatment protocols / proposed technology / Therapy for Head and Neck Cancer / /
MedicalCondition
localized tumors / secondary cancers / JE / better tumor / Childhood Medulloblastoma / involved tumor / melanoma / medulloblastoma / acoustic neuroma / retroperitoneal sarcoma / prostate cancer / craniopharyngioma / breast cancer / extra-large uveal melanomas / glioblastoma / chordoma observed overall survival rates / sufficient cancer / uveal melanoma / leukemia / tumor / cancer / Nasopharyngeal Carcinoma / tumors / NSCLC / cervical spine tumors / Hepatocellular Carcinoma / target tumor / gland tumors / lymphomas / intracranial arteriovenous malformations / benign tumors / medulloblastoma / metastases / astrocytoma / intracranial atypical and malignant meningioma / chordoma reported five-year survival rates / malignant central nervous system tumors / chondrosarcoma / chondrosarcomas / Solid tumors / oral tumors / Acoustic Neuromas / extremity sarcoma / cerebral arteriovenous malformations / nasopharyngeal tumors / Skull Base Meningiomas / chordoma / arteriovenous malformations / head and neck cancer / ocular tumors / hearing loss / chordomas / I Non-Small-Cell Lung Cancer / Lung cancers / relatively rare cancers / cancers / Early and Advanced Breast Cancer / benign and atypical meningioma / Pituitary neoplasms / bone tumors / Hodgkin Lymphoma / certain cancers / Lung Cancer / growth hormone deficiency / pediatric cancers / Intraocular melanomas / uveal melanomas / /
Loma Linda University / Medicare / Public Health Council / Northeast Proton Therapy Center / Paul Scherrer Institut / State Hospital Review / FDA / University of California - San Francisco / U.S. National Cancer Institute / Department of Health / Planning Council / State Hospital Review and Planning Council FROM / American Health Lawyers Association / University of Pennsylvania / Massachusetts General Hospital / SHRPC / U.S. Food and Drug Administration / University of Tsukaba / University of Florida / Agency for Healthcare Research and Quality / /
Person
Thomas Jung Acting / Bush / Arch Opthalmology / /
Position
contractor / Director / Division of Health Facility Planning DATE / principal investigator / consumer representative / Commissioner / /
Product
PBT / /
ProvinceOrState
Indiana / New York / Connecticut / Oklahoma / California / New Jersey / Pennsylvania / Florida / Massachusetts / /
PublishedMedium
the State Hospital Review / Cancer Research / The Cancer Journal / British Journal of Cancer / /
Memorandum: Proton Beam Therapy